Company Backgrounder

InSource Diagnostics is a CLIA-certified clinical laboratory that performs blood, urine and saliva testing. The company's drug compliance monitoring services support pain management, psychiatry, OB-GYN, internal medicine and general practitioners who prescribe controlled substances for periods of more than 90 days. InSource’s new Sensieva blood testing platform incorporates minimally invasive sampling methods including fingertip collection for a rapidly expanding menu of routine and specialized tests. 

Founded by scientists, InSource Diagnostics re-invests a significant portion of its revenue in R&D to broaden its menu of tests, simplify sample collection and improve accuracy. One of the largest labs in California, InSource Diagnostics operates a 7,290 square-foot testing facility at its headquarters in Monrovia. Founded in 2012, InSource Diagnostics serves customers throughout the country and maintains a national sales force located strategically throughout the U.S.

InSource places considerable emphasis on clinical research to support the development of new and innovative tests. The company recently began accepting enrollment in its SPHERE clinical trial. This trial is designed to validate biomarkers discovered in urine that predict genetic mutations in the cytochrome P450 family of liver enzymes, which affect a patient’s ability to properly metabolize medications (Trial Number: NCT02625155).

Contacts for the Media: 
Jennifer Dahlgren, Dahlgren Communications
(530) 263-6817

Sky Countryman, CEO, InSource Diagnostics
(626) 386-5277

Changing the World. One Test at a Time.

Contact Us

231 W. Chestnut Ave. Monrovia, CA 91016
Office: (626) 386-5277 | Fax: (888) 677-7748 |

Follow Us

Facebook Instagram LinkedIn Youtube Twitter

HIPAA | Terms and Conditions | Privacy Policy

© 2018 InSource Diagnostics. All Rights Reserved.